These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6802651

  • 1. Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia.
    Carlson LA.
    Eur J Clin Invest; 1982 Feb; 12(1):41-53. PubMed ID: 6802651
    [Abstract] [Full Text] [Related]

  • 2. Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia.
    Carlson LA, Philipson B.
    Lancet; 1979 Nov 03; 2(8149):922-4. PubMed ID: 91022
    [Abstract] [Full Text] [Related]

  • 3. Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects.
    Carlson LA, Holmquist L.
    Acta Med Scand; 1985 Nov 03; 218(2):197-205. PubMed ID: 4061123
    [Abstract] [Full Text] [Related]

  • 4. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
    Klein HG, Lohse P, Pritchard PH, Bojanovski D, Schmidt H, Brewer HB.
    J Clin Invest; 1992 Feb 03; 89(2):499-506. PubMed ID: 1737840
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of normal high density lipoproteins on lecithin:cholesterol acyltransferase activity in fish eye disease plasma.
    Holmquist L, Carlson LA.
    Acta Med Scand; 1987 Feb 03; 222(1):15-21. PubMed ID: 3630774
    [Abstract] [Full Text] [Related]

  • 6. Evidence for deficiency of high density lipoprotein lecithin: cholesterol acyltransferase activity (alpha-LCAT) in fish eye disease.
    Carlson LA, Holmquist L.
    Acta Med Scand; 1985 Feb 03; 218(2):189-96. PubMed ID: 4061122
    [Abstract] [Full Text] [Related]

  • 7. The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease.
    Assmann G, Schmitz G, Heckers H.
    Scand J Clin Lab Invest Suppl; 1978 Feb 03; 150():98-102. PubMed ID: 218282
    [Abstract] [Full Text] [Related]

  • 8. Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease.
    Carlson LA, Holmquist L, Assmann G.
    Acta Med Scand; 1987 Feb 03; 222(4):345-50. PubMed ID: 3425387
    [Abstract] [Full Text] [Related]

  • 9. Familial LCAT deficiency and fish-eye disease.
    McIntyre N.
    J Inherit Metab Dis; 1988 Feb 03; 11 Suppl 1():45-56. PubMed ID: 3141686
    [Abstract] [Full Text] [Related]

  • 10. Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent.
    Kastelein JJ, Pritchard PH, Erkelens DW, Kuivenhoven JA, Albers JJ, Frohlich JJ.
    J Intern Med; 1992 Apr 03; 231(4):413-9. PubMed ID: 1588268
    [Abstract] [Full Text] [Related]

  • 11. In vitro normalization of cholesteryl ester content and particle size of fish eye disease high density lipoproteins.
    Holmquist L, Carlson LA.
    Acta Med Scand; 1987 Apr 03; 221(3):283-9. PubMed ID: 3591466
    [Abstract] [Full Text] [Related]

  • 12. Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins.
    Sakaguchi S.
    Microbiol Immunol; 1982 Apr 03; 26(11):1017-34. PubMed ID: 6220193
    [Abstract] [Full Text] [Related]

  • 13. Fish-eye disease: Another under-recognized cause of familial corneal opacification.
    Kapoor S.
    Ophthalmic Genet; 2016 Sep 03; 37(3):349. PubMed ID: 26854387
    [No Abstract] [Full Text] [Related]

  • 14. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.
    Norum KR, Glomset JA, Nichols AV, Forte T, Albers JJ, King WC, Mitchell CD, Applegate KR, Gong EL, Cabana V.
    Scand J Clin Lab Invest Suppl; 1975 Sep 03; 142():31-55. PubMed ID: 169567
    [Abstract] [Full Text] [Related]

  • 15. A fish-eye disease-like familial condition with massive corneal clouding and dyslipoproteinemia. Report of clinical, histologic, electron microscopic, and biochemical features.
    Koster H, Savoldelli M, Dumon MF, Dubourg L, Clerc M, Pouliquen Y.
    Cornea; 1992 Sep 03; 11(5):452-64. PubMed ID: 1424675
    [Abstract] [Full Text] [Related]

  • 16. Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins.
    Elkhalil L, Majd Z, Bakir R, Perez-Mendez O, Castro G, Poulain P, Lacroix B, Duhal N, Fruchart JC, Luc G.
    Metabolism; 1997 May 03; 46(5):474-83. PubMed ID: 9160810
    [Abstract] [Full Text] [Related]

  • 17. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.
    Dimick SM, Sallee B, Asztalos BF, Pritchard PH, Frohlich J, Schaefer EJ.
    J Clin Lipidol; 2014 May 03; 8(2):223-30. PubMed ID: 24636183
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.